Stents formed from polymeric materials that can be used for lumen expansion and in situ delivery of one or more therapeutic agents. The scaffold can be multi-layered and can change shape at a state transition temperature controlled by the material from which the layers are formed.
Due to the COVID-19 pandemic, the global Polymer Stent market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Polymer Stent market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Polymer Stent landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Urinary System accounting for % of the Polymer Stent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinic segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Polymer Stent include Creomedical, Elixir Medical, ELLA-CS, Merit Medical Systems, Novatech, Shenzhen Wego Healthcare, SLTL Medical, Stening and Ace Medical Devices, etc. In terms of revenue, the global 3 largest players have a % market share of Polymer Stent in 2021.
This report focuses on Polymer Stent volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Polymer Stent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Polymer Stent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Urinary System
Respiratory System
Digestive System
Cardiovascular System
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Creomedical
Elixir Medical
ELLA-CS
Merit Medical Systems
Novatech
Shenzhen Wego Healthcare
SLTL Medical
Stening
Ace Medical Devices
Plasti-med
ROCAMED
Shandong Hua'an Biotechnology
Shenzhen MicroApproach Medical Technology
Cathwide Medical
Tianck Medical
UROMED
Endo-Flex
Guangdong Baihe Medical Technology
InSitu Technologies
Invamed
MEDpro Medical
Olympus America